新产业：近日获得1项发明专利证书

Core Viewpoint - The company has recently received a patent certificate from the National Intellectual Property Administration for an invention titled "18-OXOF antibody or its antigen-binding fragment" [2] Group 1 - The patent certificate signifies a potential advancement in the company's research and development efforts [2] - The invention may enhance the company's product offerings in the biotechnology sector [2] - This development could position the company favorably in the competitive landscape of antibody-based therapies [2]